A development cohort including 70 AOSD and 37 lymphoma patients was used to establish a scoring model based on the features of PET/CT images

Synaptophysin is an immunohistochemical marker for neuroendocrine differentiation and is widely used in pathologic diagnosis. Its expression in...

EBV-positive status is associated with poor OS and DSS in HL patients. EBV infection should therefore be considered a valuable prognostic marker and...

Circulating tumor DNA (ctDNA) has offered a minimally invasive approach for the detection and measurement of cancer

To define the prevalence of neuromuscular, musculoskeletal, visceral, oncologic, and other late effects affecting function and quality of life (QOL)...

Although FC diagnosis of CHL was historically considered unfeasible, our findings in a real-world clinical setting suggest that FC adds diagnostic...

T2w transverse sequences with fs yielded the highest detection rates and are well-suited for accurate whole-body PET/MRI in lymphoma patients

PLR was a robust prognostic factor for newly diagnosed early-stage cHL

The subtype and SMN risk among Hodgkin lymphoma survivors varied by race/ethnicity

Our findings highlight the need for prospective studies to examine tumour and host biology, and to test novel therapies across the age spectrum

For NLPHL, pre-therapeutic FDG-PET scan is better than CeCT staging. FDG-PET has much better specificity for response assessment than CeCT

There is a high correlation between MTV, intensity and most dissemination features derived with the different segmentation methods and the prognostic...